The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oxaliplatin-Global Market Insights and Sales Trends 2025
Synopsis
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The global Oxaliplatin market size is expected to reach US$ 1641.5 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oxaliplatin in various end use industries. The expanding demands from the Colorectal Cancer, Stomach Cancer, Ovarian Cancer and Others, are propelling Oxaliplatin market. Mannitol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glucose Solution segment is estimated at % CAGR for the next seven-year period.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxaliplatin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxaliplatin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxaliplatin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxaliplatin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxaliplatin covered in this report include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan and Jiangsu Hengrui Medicine, etc.
The global Oxaliplatin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Global Oxaliplatin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxaliplatin market, Segment by Type:
Mannitol
Glucose Solution
Lactose Solution
Others
Global Oxaliplatin market, by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oxaliplatin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The global Oxaliplatin market size is expected to reach US$ 1641.5 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oxaliplatin in various end use industries. The expanding demands from the Colorectal Cancer, Stomach Cancer, Ovarian Cancer and Others, are propelling Oxaliplatin market. Mannitol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glucose Solution segment is estimated at % CAGR for the next seven-year period.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxaliplatin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxaliplatin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxaliplatin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxaliplatin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxaliplatin covered in this report include Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan and Jiangsu Hengrui Medicine, etc.
The global Oxaliplatin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Global Oxaliplatin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxaliplatin market, Segment by Type:
Mannitol
Glucose Solution
Lactose Solution
Others
Global Oxaliplatin market, by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oxaliplatin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oxaliplatin
1.1 Oxaliplatin Market Overview
1.1.1 Oxaliplatin Product Scope
1.1.2 Oxaliplatin Market Status and Outlook
1.2 Global Oxaliplatin Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oxaliplatin Market Size by Region (2018-2029)
1.4 Global Oxaliplatin Historic Market Size by Region (2018-2023)
1.5 Global Oxaliplatin Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oxaliplatin Market Size (2018-2029)
1.6.1 North America Oxaliplatin Market Size (2018-2029)
1.6.2 Europe Oxaliplatin Market Size (2018-2029)
1.6.3 Asia-Pacific Oxaliplatin Market Size (2018-2029)
1.6.4 Latin America Oxaliplatin Market Size (2018-2029)
1.6.5 Middle East & Africa Oxaliplatin Market Size (2018-2029)
2 Oxaliplatin Market by Type
2.1 Introduction
2.1.1 Mannitol
2.1.2 Glucose Solution
2.1.3 Lactose Solution
2.1.4 Others
2.2 Global Oxaliplatin Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oxaliplatin Historic Market Size by Type (2018-2023)
2.2.2 Global Oxaliplatin Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oxaliplatin Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oxaliplatin Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oxaliplatin Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oxaliplatin Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oxaliplatin Revenue Breakdown by Type (2018-2029)
3 Oxaliplatin Market Overview by Application
3.1 Introduction
3.1.1 Colorectal Cancer
3.1.2 Stomach Cancer
3.1.3 Ovarian Cancer
3.1.4 Others
3.2 Global Oxaliplatin Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oxaliplatin Historic Market Size by Application (2018-2023)
3.2.2 Global Oxaliplatin Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oxaliplatin Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oxaliplatin Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oxaliplatin Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oxaliplatin Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oxaliplatin Revenue Breakdown by Application (2018-2029)
4 Oxaliplatin Competition Analysis by Players
4.1 Global Oxaliplatin Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxaliplatin as of 2022)
4.3 Date of Key Players Enter into Oxaliplatin Market
4.4 Global Top Players Oxaliplatin Headquarters and Area Served
4.5 Key Players Oxaliplatin Product Solution and Service
4.6 Competitive Status
4.6.1 Oxaliplatin Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi-Aventis
5.1.1 Sanofi-Aventis Profile
5.1.2 Sanofi-Aventis Main Business
5.1.3 Sanofi-Aventis Oxaliplatin Products, Services and Solutions
5.1.4 Sanofi-Aventis Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi-Aventis Recent Developments
5.2 Yakult honsha
5.2.1 Yakult honsha Profile
5.2.2 Yakult honsha Main Business
5.2.3 Yakult honsha Oxaliplatin Products, Services and Solutions
5.2.4 Yakult honsha Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.2.5 Yakult honsha Recent Developments
5.3 Dr Reddy's laboratories
5.3.1 Dr Reddy's laboratories Profile
5.3.2 Dr Reddy's laboratories Main Business
5.3.3 Dr Reddy's laboratories Oxaliplatin Products, Services and Solutions
5.3.4 Dr Reddy's laboratories Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.3.5 Sun Pharmaceutical Recent Developments
5.4 Sun Pharmaceutical
5.4.1 Sun Pharmaceutical Profile
5.4.2 Sun Pharmaceutical Main Business
5.4.3 Sun Pharmaceutical Oxaliplatin Products, Services and Solutions
5.4.4 Sun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.4.5 Sun Pharmaceutical Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Oxaliplatin Products, Services and Solutions
5.5.4 Teva Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Recent Developments
5.6 Fresenius Kabi
5.6.1 Fresenius Kabi Profile
5.6.2 Fresenius Kabi Main Business
5.6.3 Fresenius Kabi Oxaliplatin Products, Services and Solutions
5.6.4 Fresenius Kabi Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.6.5 Fresenius Kabi Recent Developments
5.7 Hospira
5.7.1 Hospira Profile
5.7.2 Hospira Main Business
5.7.3 Hospira Oxaliplatin Products, Services and Solutions
5.7.4 Hospira Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.7.5 Hospira Recent Developments
5.8 Mylan
5.8.1 Mylan Profile
5.8.2 Mylan Main Business
5.8.3 Mylan Oxaliplatin Products, Services and Solutions
5.8.4 Mylan Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.8.5 Mylan Recent Developments
5.9 Jiangsu Hengrui Medicine
5.9.1 Jiangsu Hengrui Medicine Profile
5.9.2 Jiangsu Hengrui Medicine Main Business
5.9.3 Jiangsu Hengrui Medicine Oxaliplatin Products, Services and Solutions
5.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.9.5 Jiangsu Hengrui Medicine Recent Developments
5.10 Nanjing Pharmaceutical Factory
5.10.1 Nanjing Pharmaceutical Factory Profile
5.10.2 Nanjing Pharmaceutical Factory Main Business
5.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Products, Services and Solutions
5.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.10.5 Nanjing Pharmaceutical Factory Recent Developments
5.11 Jiangsu Aosaikang Pharmaceutical
5.11.1 Jiangsu Aosaikang Pharmaceutical Profile
5.11.2 Jiangsu Aosaikang Pharmaceutical Main Business
5.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products, Services and Solutions
5.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
5.12 Qilu Pharmaceutical
5.12.1 Qilu Pharmaceutical Profile
5.12.2 Qilu Pharmaceutical Main Business
5.12.3 Qilu Pharmaceutical Oxaliplatin Products, Services and Solutions
5.12.4 Qilu Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.12.5 Qilu Pharmaceutical Recent Developments
5.13 Hisun Pharmaceutical
5.13.1 Hisun Pharmaceutical Profile
5.13.2 Hisun Pharmaceutical Main Business
5.13.3 Hisun Pharmaceutical Oxaliplatin Products, Services and Solutions
5.13.4 Hisun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.13.5 Hisun Pharmaceutical Recent Developments
5.14 Lunan Pharmaceutical
5.14.1 Lunan Pharmaceutical Profile
5.14.2 Lunan Pharmaceutical Main Business
5.14.3 Lunan Pharmaceutical Oxaliplatin Products, Services and Solutions
5.14.4 Lunan Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.14.5 Lunan Pharmaceutical Recent Developments
5.15 Luoxin
5.15.1 Luoxin Profile
5.15.2 Luoxin Main Business
5.15.3 Luoxin Oxaliplatin Products, Services and Solutions
5.15.4 Luoxin Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.15.5 Luoxin Recent Developments
5.16 Halfsky Pharmacy
5.16.1 Halfsky Pharmacy Profile
5.16.2 Halfsky Pharmacy Main Business
5.16.3 Halfsky Pharmacy Oxaliplatin Products, Services and Solutions
5.16.4 Halfsky Pharmacy Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.16.5 Halfsky Pharmacy Recent Developments
5.17 YRPG
5.17.1 YRPG Profile
5.17.2 YRPG Main Business
5.17.3 YRPG Oxaliplatin Products, Services and Solutions
5.17.4 YRPG Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.17.5 YRPG Recent Developments
5.18 Hainan Jinrui Pharmaceutical
5.18.1 Hainan Jinrui Pharmaceutical Profile
5.18.2 Hainan Jinrui Pharmaceutical Main Business
5.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Products, Services and Solutions
5.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.18.5 Hainan Jinrui Pharmaceutical Recent Developments
5.19 Jari Pharmaceutical
5.19.1 Jari Pharmaceutical Profile
5.19.2 Jari Pharmaceutical Main Business
5.19.3 Jari Pharmaceutical Oxaliplatin Products, Services and Solutions
5.19.4 Jari Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.19.5 Jari Pharmaceutical Recent Developments
5.20 Chiatai Tianqing
5.20.1 Chiatai Tianqing Profile
5.20.2 Chiatai Tianqing Main Business
5.20.3 Chiatai Tianqing Oxaliplatin Products, Services and Solutions
5.20.4 Chiatai Tianqing Oxaliplatin Revenue (US$ Million) & (2018-2023)
5.20.5 Chiatai Tianqing Recent Developments
6 North America
6.1 North America Oxaliplatin Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oxaliplatin Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oxaliplatin Market Dynamics
11.1 Oxaliplatin Industry Trends
11.2 Oxaliplatin Market Drivers
11.3 Oxaliplatin Market Challenges
11.4 Oxaliplatin Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
